Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Prostate Cancer / October 2005

Tip: Looking for answers? Try searching our database.

The Average PCa Patient

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
ron - 19 Oct 2005 17:45 GMT
In a recent paper (WHO IS THE AVERAGE PATIENT PRESENTING WITH
PROSTATE CANCER?; KIRSTEN L. GREENE, JANET E. COWAN, MATTHEW R.
COOPERBERG, MAXWELL V. MENG, JANEEN DUCHANE, AND PETER R. CARROLL;
UROLOGY 66 (Suppl 5A): 76-82, 2005), the demographics of 3003 men
from the CaPSURE database who were diagnosed with PCa between 1997 and
2003 were analyzed.  The authors found that, "the 'average' prostate
cancer patient is white, 65 years of age, overweight, educated at a
college level, and has 1 to 2 comorbidities.  Patients report average
or above-average pretreatment health-related QOL."

In terms of risk groups, "In the group of patients diagnosed in 2000 to
2003, 48% were low risk, 33% were intermediate risk, and 18% were high
risk."

Treatment selection broke down as follows:

                     1997-1999, n (%)   2000-2003, n (%)
Radical prostatectomy    171 (52)        1249 (58)
Cryosurgery                7 (2)           73 (3)
Brachytherapy             88 (27)         444 (21)
External beam radiation   43 (13)         214 (10)
Orchiectomy                0 (0)            1 (<1)
LHRH agonist               9 (3)           92 (4)
LHRH antagonist            2 (1)            2 (<1)
Antiandrogen               2 (1)           14 (1)
5a-reductase inhibitor     1 (<1)           1 (<1)
Watchful waiting           4 (1)           50 (2)

...Best wishes and good health, Ron
Steve Jordan - 19 Oct 2005 19:35 GMT
On October 19, ron posted:

> In a recent paper (WHO IS THE AVERAGE PATIENT PRESENTING WITH
> PROSTATE CANCER?; KIRSTEN L. GREENE, JANET E. COWAN, MATTHEW R.
[quoted text clipped - 5 lines]
> college level, and has 1 to 2 comorbidities.  Patients report average
> or above-average pretreatment health-related QOL."

I'd like to read the original article, but am unable to find it using the
reference ron provided. I'd very much appreciate further info.

Frex, what is the exact title of the publication? Is it online? It
apparently is not the Journal of Urology nor the Johns Hopkins publication
entitled, "Urology."

Thanks!

Regards,

Steve J
Steve Jordan - 19 Oct 2005 19:40 GMT
I just wrote:

> On October 19, ron posted:
>
[quoted text clipped - 14 lines]
> apparently is not the Journal of Urology nor the Johns Hopkins
> publication entitled, "Urology."

Never mind; found it on PubMed.

Regards,

Steve J
USC Gamecock - 19 Oct 2005 22:42 GMT
Wonder what I do to that average?!?!?   ;-)

Wish me luck boys -- I'm gonna pick up the golf clubs this weekend and
see what happens.  It's been 10 weeks post RRP so I think I'm ready to
try to hit 'em.

Diagnosed -- 6/22/05, Age 37
Clinical T2b, Gleason Sum 6 (3+3)
RRP - August 12, 2005; Johns Hopkins (Alan Partin, MD)
Pathological Gleason Sum 6; confined to prostate
No Seminal Vesicle or Lymph Node Involvement
Lamentations 3:21-23
Steve Jordan - 20 Oct 2005 00:09 GMT
> Wish me luck boys -- I'm gonna pick up the golf clubs this weekend and
> see what happens.  It's been 10 weeks post RRP so I think I'm ready to
> try to hit 'em.

Whack the cover off the ball!

Straight down the fairway, of course ;-)

> Diagnosed -- 6/22/05, Age 37

Somehow I had missed that age at dx. Were there symptoms, or was this beast
discovered in the normal course of a physical exam?

> Clinical T2b, Gleason Sum 6 (3+3)
> RRP - August 12, 2005; Johns Hopkins (Alan Partin, MD)
> Pathological Gleason Sum 6; confined to prostate
> No Seminal Vesicle or Lymph Node Involvement

Looks like a good start on recovery. I hope it stays that way -- low PSAs
forevermore.

> Lamentations 3:21-23

21 This I recall to my mind, therefore have I hope.
22 It is of the Lord's mercies that we are not consumed, because his
compassions fail not.
23 They are new every morning: great is thy faithfulness.

....and I'll add this: 24 The Lord is my portion, saith my soul; therefore
will I hope in him.

For a man who is uncertain, I do find a lot of food for thought in the
Bible. I will go no further than that.

Regards,

Steve J

"The silence of a falling star
lights up the purple sky
And while I wonder where you are
I'm so lonesome I could cry"
--Hank Williams
David S. - 20 Oct 2005 12:55 GMT
Have a great time.  I hope the weather cooperates.

> Wonder what I do to that average?!?!?   ;-)
>
[quoted text clipped - 8 lines]
> No Seminal Vesicle or Lymph Node Involvement
> Lamentations 3:21-23
Leonard Evens - 20 Oct 2005 15:03 GMT
> In a recent paper (WHO IS THE AVERAGE PATIENT PRESENTING WITH
> PROSTATE CANCER?; KIRSTEN L. GREENE, JANET E. COWAN, MATTHEW R.
[quoted text clipped - 25 lines]
>
> ...Best wishes and good health, Ron

Interesting.

I wonder why the sample was 3003 cases when their database, according to
the CAPSure website includes 11,000 patients.

Another suprise is that the typical patient is college educated.  Since
the typical American man of that age is not college educated, what is
happening to all those other men?   Is it possible that they are not
being treated at all and hence contributing significantly to the death
rate from prostate cancer?  Alternately, of course, it may be that the
CAPSure database is strongly biased towards college educated men because
of the selection of participating clinics.
Leonard Evens - 20 Oct 2005 15:36 GMT
> In a recent paper (WHO IS THE AVERAGE PATIENT PRESENTING WITH
> PROSTATE CANCER?; KIRSTEN L. GREENE, JANET E. COWAN, MATTHEW R.
[quoted text clipped - 25 lines]
>
> ...Best wishes and good health, Ron

I went and looked at the paper, and I must say I am unimpressed.   The
data is interesting, but instead of trying to simplify it by broad
statements which are not meaningful, they should just have reported what
they found.

Since they just examined the patients in their database, they don't know
whether or not results flow from bias in the selection process or have
something to do with prostate cancer.   Consider the education issue.
They state that over 60 percent of the patients had some college
education compared to 52 percent nationally.  But maybe the clinics
participating in the study were fed from a population which had higher
than average college education.  That could result for example from
concentration in urban areas or for other reasons.  Or it could result
from a bias towards insurance coverage.  Later they do seem to note that
college education seemed somewhat associated with early detection in the
database, and that would seem to be an interesting, though hardly
surprising, conclusion.

Also, consider the overweight conclusion.   It is not clear from the
article what they are comparing to.  Perhaps older men as a group are
just overweight and this has nothing to do with prostate cancer.
Comparing 1997-99 to 2000-2003 in their database, they find a decrease
of men in the BMI category 'normal weight' of about 4 percent, no
signficnat change in the category 'overweight' (a decrease of 1
percent), and an increase in the category 'obese' of about 5 percent.
This does seem to show a small increase in increased weight of patients,
but what it has to do with prostate cancer is not clear.  And it might
just represent a change in the population being sampled.

One figure they report suggests something very fishy to me.  In 1997-99
the percentage of African American patients was 11 percent, but in
2000-2003 it dropped to 5 percent.   The 11 percent figure suggests a
bias in the sample to begin with, since African American men are more
likely to get prostate cancer in the first place.  But it is not
believable that incidence of prostate cancer in African American men
actually dropped in half in that period of time.   This suggests that
their database is highly skewed in important ways, and some of their
demographic conclusions are measures of the populations from which the
participating clinics selected patients than they are of prostate cancer
patients.
Alan Meyer - 21 Oct 2005 01:06 GMT
> ...
> I went and looked at the paper, and I must say I am unimpressed.   The
> data is interesting, but instead of trying to simplify it by broad
> statements which are not meaningful, they should just have reported what
> they found.
> ...

Thanks for the analysis.  If you feel ambitious, you might
want to send it to the journal that published this stuff.
Maybe the editors will be embarrassed enough to review the
submissions more carefully before they publish them.

It always surprises me to see some of the rubbish that can
slip through into respectable, peer reviewed, journals -
which I thought _Urology_ was.

   Alan
ron - 23 Oct 2005 19:02 GMT
> I went and looked at the paper, and I must say I am unimpressed.   The
> data is interesting, but instead of trying to simplify it by broad
[quoted text clipped - 36 lines]
> participating clinics selected patients than they are of prostate cancer
> patients.

Leonard...Your points are well taken, but I would caution against
"throwing the baby out with the bath water."  The authors are only
sampling something on the order of 0.1-0.2% of those individuals
diagnosed within the US over the course of their study and this will
lead to some error.  Their 40 data collection clinics probably do not
accurately represent the entire US population, although I suspect they
were selected in some manner to try and approximate this population.
The 3,000 men selected for this study (out of the 11,000 men in the
CaPSURE database) are further self-selected in that they took the time
to fill out both QOL questionnaires.  While I do not know the magnitude
of the error introduced by these and other sampling deficiencies, I do
not expect it to be large enough to rearrange the sequencing of the
major treatment categories or the (surprising to me) significant
percentage of non-low risk men still being diagnosed today.  On the
other hand, trying to make sense out of small percentage differences is
unwise.

CaPSURE is an attempt to collect meaningful data to use in PCa
treatment and policy decisison making.  It is a welcome start (IMO) to
answer questions that are important to all of us.  Does a larger, more
accurate database exist somewhere else?..Best wishes and good health,
Ron
Alan Meyer - 25 Oct 2005 22:28 GMT
...
> The 3,000 men selected for this study (out of the 11,000 men in the
> CaPSURE database) are further self-selected in that they took the time
[quoted text clipped - 3 lines]
> major treatment categories or the (surprising to me) significant
> percentage of non-low risk men still being diagnosed today.
...

I understand what you're saying here Ron, but the problem with
sampling errors is that there's no good way to know what the
effects are.  The very one you pointed out, self selection in
filling out QOL questionnaires is a perfect example.  It's
entirely possible that certain kinds of problems are systematically
under or over represented in such self-selections.  The data
may be representative, but it may not.  We just don't know.

I don't have Leonard's extensive background in statistics, but
in my courses in statistics and experimental study design (all
two of them :-)) the criticality of random sampling was emphasized
over and over again.  The professors were deeply concerned to
pound it into our heads that if we don't have a truly random
sample, we just don't know what we've got and can't draw
valid conclusions about the population at large.

   Alan
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.